LIFERA
Updated 25 days ago
Lifera is a new biopharmaceutical company, wholly owned by the Public Investment Fund (PIF). We are dedicated to advancing Saudi Arabia's biopharmaceutical sector and building national health resilience. Lifera aims to become a leading biopharma Contract Development and Manufacturing Organization (CDMO), ensuring Saudi Arabia achieves biopharma resilience and a thriving biotech sector. We thrive to build local manufacturing capacity for vaccines, insulin, plasma therapeutics and other biologics, and investing in genetic testing and precision medicine.